期刊文献+

高龄冠心病患者PCI治疗效果及安全性探讨 被引量:5

Effect and Safety of PCI Used for Patients over 80 Years Old with Coronary Heart Disease
下载PDF
导出
摘要 目的探讨80岁以上高龄冠心病(CHD)患者PCI治疗效果和安全性.方法选择2006年10月—2010年12月在北华大学附属医院心脏中心住院接受PC I治疗的80岁以上高龄CHD不稳定性心绞痛患者78例(高龄组),和同期住院接受PCI治疗的40~60岁的中年CHD不稳定性心绞痛患者216例(中年组),比较两组HCD患者易患因素、冠脉病变的Syntax评分、植入支架的数量及长度、效果和并发症等.结果易患因素在高龄组与中年组分别合并高血压病有8.9%与30.1%,糖尿病有12.6%与35.2%,吸烟有1%与72.9%,高血脂有5.9%与32.1%,两组比较差异有统计学意义(P〈0.05).高龄组和中年组冠脉造影(CAG)示单支血管病变分别为20.5%和35.2%,双支血管病变为35.9%和46.8%,三支血管病变为44.9%和22.7%,冠脉病变的Syntax评分分别是20.9±6.7与14.6±7.8(P〉0.05);平均每例植入支架的数量为(2.53±0.67)个与(1.92±0.86)个,植入支架长度为(23.01±5.88)mm与(18.67±5.01)mm(P〈0.05).TIMI血流Ⅲ级率、急性或亚急性血栓发生率、出血性并发症、术中和术后1个月的死亡率两组无统计学意义(P〉0.05).结论 80岁以上高龄冠心病患者行PCI治疗,近期效果和安全性与中年组相同. Objective To explore effect and safety of PCI used for the treatment of patients over 80 years old with coronary heart disease(CHD).Method 78 cases over 80 years old with CHD unstable angina(older group) and without serious brain,lung,kidney and valve lesions and 216 cases in their ages from 40 to 60 years old with CHD unstable angina(middle aged-group) were selected,which were hospitalized for PCI therapy in the cardiovascular center of Affiliated Hospital of Beihua University from October 2006 to December 2010.The susceptibility factors,Syntax score of coronary lesions,stent's number and length,effect and safety and so on were comparatively researched.Results The susceptibility factors were some complications,such as hypertension 8.9% and 30.1%,diabetes 12.6% and 35.2%,smoking 1% and 72.9%,and dyslipidemia 5.9% and 32.1% respectively in older group and middle-aged group(P0.05).In the older group and middle-aged group,CAG showed that single branch lesions were 20.5% and 35.2%,double branches lesions were 35.9% and 46.8%,three branches lesions were 44.9% and 22.7%.Syntax score of coronary lesions was 20.9± 6.7 and 14.6±7.8(P0.05),and the number of implanted stents on average every example was(x±s)2.53±0.67 and 1.92±0.86,with the stent length(x±S)23.01±5.88mm and 18.67±5.01mm.(P0.05).The rate of TIMI flow was level 3,but the incidence of acute or sub-acute thrombosis,the hemorrhagic complications and the mortality during the operation and postoperative one month were not significantly different(P0.05).Conclusion The recent effect and the safety in the more than 80 years old patients with coronary heart disease(CHD) treated by PCI were as same as those of middle-aged group.
出处 《北华大学学报(自然科学版)》 CAS 2011年第3期312-315,共4页 Journal of Beihua University(Natural Science)
基金 吴阶平医学基金资助课题(55-A)
关键词 高龄 心绞痛 PCI 效果 安全性 elderly patient CHD unstable angina pectoris PCI effect safety
  • 相关文献

参考文献4

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2136
  • 2AraozP A, Kirsch J, Primak AN, et al. Dual-Source Computed Tomographic Temporal Resolution Provides Higher Image Quality than 64-Detector Temporal Res- olution at Low Heart Rates[ J]. J Comput Assist Tomogr, 2010,34( 1 ) :64-69.
  • 3Polewczyk A, Janion M, Gasior M, et al. Benefits from Revascularisation Therapy in the Elderly with Acute Myocardial Infarction. Comparative Analysis of Patients Hospitalised in 1992-1996 and in 2005-2006 [ J]. Kardiol Pol,2010,68(8) :873-881.
  • 4Vatente S, Lazzeri C, Salvadori C, et al. Effectiveness and Safety of Routine Primary Angioplasty in Patients Aged > or = 85 Years with Acute Myocardial Infarction [ J ]. Circ J ,2008,72( 1 ) :67-70.

二级参考文献24

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2135

同被引文献21

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部